Targeting SHP2 phosphatase in breast cancer overcomes RTK-mediated resistance to PI3K inhibitors.

Heynen GJJE, Lisek K, Vogel R, Wulf-Goldenberg A, Alcaniz J, Montaudon E, Marangoni E, Birchmeier W
Breast Cancer Res. 2022 Apr 1;24(1):23. doi: 10.1186/s13058-022-01521-3. PubMed Article

Plasmids from Article

No plasmids are currently publicly available from Addgene for this article.